Abraham L Bayer

11PUBLICATIONS
36CO-AUTHORS
Haematological tumoursMolecular targetsMedical mycologyTumour immunologyReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 17, 2025
Targeting of Cdc42-Interacting Protein 4-Calcineurin Signalosomes Improves Cardiac Structure and Function After Myocardial Infarction.

Anne-Maj Samuelsson, Abraham L Bayer, Jinliang Li

|Oct 09, 2025
When Resident Macrophages Call, Fibroblasts Answer: CCL24-CCR3 in Fibrosis.

Abraham L Bayer, Pilar Alcaide

|Jun 04, 2025
Targeting of CIP4-Calcineurin Signalosomes Improves Cardiac Structure and Function After Myocardial Infarction.

Anne-Maj Samuelsson, Abraham L Bayer, Jinliang Li

|Mar 12, 2025
MyD88 determines T cell fate through BCAP-PI3K signaling.

Abraham L Bayer, Zoie Magri, Hayley Muendlein

|Feb 11, 2025
Novel Therapeutic Approach Targeting CXCR3 to Treat Immunotherapy Myocarditis.

Yuhsin Vivian Huang, Yin Sun, Harrison Chou

Pageof 2